Literature DB >> 21674851

The potential role of hypofractionated accelerated radiotherapy to cosmesis for stage I-II breast carcinoma: a prospective study.

A G Zygogianni1, V Kouloulias, C Armpilia, M Balafouta, C Antypas, J R Kouvaris.   

Abstract

PURPOSE: To evaluate the acute and late effects as well as the cosmetic results of an accelerated hypofractionated radiotherapeutic schedule in breast cancer irradiation.
METHODS: Fifty-four patients with stage I-II invasive breast cancer receiving postoperative radiotherapy (RT) after lumpectomy and axillary node dissection were studied. All patients received RT with 6 MV linear accelerator with a total tumor dose of 53 Gy (Equivalent dose-EQD2- 60 Gy), 2.65 Gy per fraction, in 20 fractions. Acute and late effects as well as cosmetic results were assessed using the European Organization for Research and Treatment of Cancer and Radiation Therapy Oncology Group (EORTC-RTOG) Cosmetic Rating System.
RESULTS: By the end of RT 66.7% of the patients developed no toxicity, while 24.1% showed grade 1 and 9.3% grade 2 acute skin toxicity. After 6 months 90.7% of women showed grade 0 late toxicity while 100% of women recovered completely 2 years after RT. There was no local or distant recurrence during 5-year follow up.
CONCLUSION: The accelerated hypofractionated schedule appears to be an acceptable alternative to the traditional longer RT schedules, without late toxicity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21674851

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  4 in total

1.  A Retrospective Analysis of Toxicity and Efficacy for 2 Hypofractionated Irradiation Schedules Versus a Conventional One for Post-Mastectomy Adjuvant Radiotherapy in Breast Cancer.

Authors:  Vassilis Kouloulias; Eftychia Mosa; Anna Zygogianni; Efrosini Kypraiou; John Georgakopoulos; Kalliopi Platoni; Christos Antypas; George Kyrgias; Maria Tolia; Christos Papadimitriou; Amanda Psyrri; George Patatoukas; Maria Dilvoi; Christina Armpilia; Kyriaki Theodorou; Maria-Aggeliki Kalogeridi; Ivelina Beli; John Kouvaris; Nikolaos Kelekis
Journal:  Breast Care (Basel)       Date:  2016-09-28       Impact factor: 2.860

2.  Adjuvant chemotherapy and acute toxicity in hypofractionated radiotherapy for early breast cancer.

Authors:  Vassilis Kouloulias; Anna Zygogianni; Efrosini Kypraiou; John Georgakopoulos; Zoi Thrapsanioti; Ivelina Beli; Eftychia Mosa; Amanta Psyrri; Christos Antypas; Christina Armbilia; Maria Tolia; Kalliopi Platoni; Christos Papadimitriou; Nikolaos Arkadopoulos; Costas Gennatas; George Zografos; George Kyrgias; Maria Dilvoi; George Patatoucas; Nikolaos Kelekis; John Kouvaris
Journal:  World J Clin Cases       Date:  2014-11-16       Impact factor: 1.337

3.  Sucralfate gel as a radioprotector against radiation induced dermatitis in a hypo-fractionated schedule: a non-randomized study.

Authors:  V Kouloulias; C Asimakopoulos; M Tolia; G Filippou; K Platoni; M Dilvoi; I Beli; J Georgakopoulos; G Patatoukas; N Kelekis
Journal:  Hippokratia       Date:  2013-04       Impact factor: 0.471

4.  Transformation of physical DVHs to radiobiologically equivalent ones in hypofractionated radiotherapy analyzing dosimetric and clinical parameters: a practical approach for routine clinical practice in radiation oncology.

Authors:  Zoi Thrapsanioti; Irene Karanasiou; Kalliopi Platoni; Efstathios P Efstathopoulos; George Matsopoulos; Maria Dilvoi; George Patatoukas; Demetrios Chaldeopoulos; Nikolaos Kelekis; Vassilis Kouloulias
Journal:  Comput Math Methods Med       Date:  2013-11-19       Impact factor: 2.238

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.